Waystar rises as IPO banks bullish after research quiet period ends
Corrects to JP Morgan initiates with "overweight", not "buy", in 3rd bullet
** Shares of private equity-backed healthcare payments provider Waystar WAY.O up >1% premarket after a wave of bullish reports from analysts at investment banks which underwrote its June IPO
** WAY shares on Mon closed at $21.51, a penny above the$21.50 IPO price
** JP Morgan, one of IPO's lead bookrunners, initiates coverage at "overweight" with $24 PT
** Waystar has significant room to grow in $15 bln addressable market growing 5% annually, as solutions adoption driven by growing number and complexity of healthcare payments and greater utilization of advanced RCM (revenue cycle management) technologies such as AI, JP Morgan says in note
** Evercore starts with "outperform" and $25 PT, citing co's strong portfolio of subscription and volume-based solutions, "unparalleled" customer service, while delivering "softwarelike" margins and HSD+ growth with minimal churn
** RBC slaps "outperform" rating on WAY with $27 PT, and points to post-IPO leverage of ~3.8x, saying co expects to work leverage down to 2x or below over time via its "significant" recurring revenue and high cash conversion
** Other bullish ratings include: Raymond James ("outperform", $30 PT); Deutsche Bank ("buy", $27 PT); William Blair ("outperform")
** Swedish PE firm EQT EQTAB.ST has 29.2% stake in Waystar, while Canada Pension Plan Investment Board and Bain Capital own stakes of 22.3% and 16.8%, respectively
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
